Table 2.
Incidence (pmarp) by cause of stage 5 CKD and year
| Cause of CKD 5 | Year | APC | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||
| Glomerulonephritis | 1.0 | 1.0 | 1.0 | 0.8 | 1.0 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | −1.0 (−4.0;+2.0) |
| CAKUT | 2.7 | 2.4 | 2.7 | 2.4 | 2.2 | 2.6 | 2.2 | 2.2 | 2.3 | 1.7 | −3.3 (−5.5; −1.0)* |
| Cystic kidneys | 0.7 | 0.8 | 0.5 | 0.5 | 0.8 | 0.7 | 0.8 | 0.9 | 0.9 | 0.6 | +2.0 (−2.8;+7.1) |
| Hereditary nephropathy | 0.4 | 0.4 | 0.5 | 0.3 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.5 | +1.8(−2.7;+6.5) |
| Ischemic kidney failure | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | −5.0 (−11.7;+2.1) |
| HUS | 0.3 | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | −4.9 (−9.7;+0.1) |
| Metabolic disorder | 0.2 | 0.3 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | −8.1 (−14.3;-1.5)* |
| Vasculitis | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | −9.0 (−18.0;+0.8) |
| Miscellaneous | 0.6 | 0.4 | 0.6 | 0.5 | 0.3 | 0.5 | 0.4 | 0.7 | 0.8 | 0.9 | +6.1 (−0.8;+13.6) |
| Missing/unknown | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | +5.2 (+1.1;+9.4)* |
pmarp, per million age-related population; CKD 5, stage 5 chronic kidney disease; CAKUT, congenital anomalies of the kidney and the urinary tract; HUS, hemolytic uremic syndrome
*Statistically significant trend